Solid phase fluoroimmunoassay for 11-deoxycortisol in serum using 21-amino-17-hydroxyprogesterone

Area of Science:

• Biochemistry
• Endocrinology
• Immunoassay Development

Background:

• 11-deoxycortisol is a crucial steroid hormone precursor.
• Accurate measurement of 11-deoxycortisol is vital for evaluating endocrine function.
• Existing assay methods may have limitations in sensitivity or practicality.

Purpose of the Study:

• To establish a novel solid-phase fluoroimmunoassay for serum 11-deoxycortisol.
• To develop a sensitive and reliable method for quantifying 11-deoxycortisol levels.
• To assess the utility of this assay in diagnosing pituitary and adrenocortical conditions.

Main Methods:

• Development of a fluoroimmunoassay using fluorescein isothiocyanate-labeled 11-deoxycortisol and antibody-conjugated beads.
• Synthesis of 21-amino-17-hydroxyprogesterone as a derivative for fluorescent labeling.
• Sample preparation involving Sephadex LH-20 column chromatography for extraction and purification.
• Validation of the assay's sensitivity, measurable range, and precision (intra- and inter-assay CVs).

Main Results:

• The assay demonstrated a minimal detection limit of 40 pg/tube.
• The measurable range for serum 11-deoxycortisol was 0.04 to 5.0 microgram/dl.
• High correlation was observed between the fluoroimmunoassay and established radioimmunoassay methods.
• Intra-assay (8.3%) and inter-assay (9.8%) coefficients of variation confirmed assay precision.

Conclusions:

• The developed solid-phase fluoroimmunoassay is a sensitive and reliable method for serum 11-deoxycortisol measurement.
• This assay provides accurate results comparable to radioimmunoassay.
• The method is well-suited for clinical assessment of pituitary and adrenocortical function.